BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6968289)

  • 1. Target-effector cell interaction in the natural killer cell system. V. Energy requirements, membrane integrity, and the possible involvement of lysosomal enzymes.
    Roder JC; Argov S; Klein M; Petersson C; Kiessling R; Andersson K; Hansson M
    Immunology; 1980 May; 40(1):107-16. PubMed ID: 6968289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in target cell DNA fragmentation induced by mouse cytotoxic T lymphocytes and natural killer cells.
    Duke RC; Cohen JJ; Chervenak R
    J Immunol; 1986 Sep; 137(5):1442-7. PubMed ID: 2943792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of human NK cell-mediated cytotoxicity. Mode of action of surface-associated proteases in the early stages of the lytic reaction.
    Lavie G; Leib Z; Servadio C
    J Immunol; 1985 Aug; 135(2):1470-6. PubMed ID: 2409153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reorientation of the Golgi apparatus and the microtubule-organizing center in the cytotoxic effector cell is a prerequisite in the lysis of bound target cells.
    Kupfer A; Dennert G; Singer SJ
    J Mol Cell Immunol; 1985; 2(1):37-49. PubMed ID: 3880506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of human cell-mediated cytotoxicity. III. Dependence of natural killing on microtubule and microfilament integrity.
    Katz P; Zaytoun AM; Lee JH
    J Immunol; 1982 Dec; 129(6):2816-25. PubMed ID: 6890568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of a dynamic role of the target cell membrane during the early stages of the natural killer cell lethal hit.
    Deem RL; Targan SR
    J Immunol; 1984 Jul; 133(1):72-7. PubMed ID: 6427347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target-effector interaction in the natural killer cell system. IV. Modulation by cyclic nucleotides.
    Roder JC; Klein M
    J Immunol; 1979 Dec; 123(6):2785-90. PubMed ID: 227959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
    Neville ME; Hiserodt JC
    J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.
    Andrews KJ; Ribas A; Butterfield LH; Vollmer CM; Eilber FC; Dissette VB; Nelson SD; Shintaku P; Mekhoubad S; Nakayama T; Taniguchi M; Glaspy JA; McBride WH; Economou JS
    Cancer Res; 2000 Nov; 60(22):6457-64. PubMed ID: 11103813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T lymphocyte-mediated cytolysis: dissociation of the binding and lytic mechanisms of the effector cell.
    Fishelson Z; Berke G
    J Immunol; 1978 Apr; 120(4):1121-6. PubMed ID: 305932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The beige mutation in the mouse. I. A stem cell predetermined impairment in natural killer cell function.
    Roder JC
    J Immunol; 1979 Nov; 123(5):2168-73. PubMed ID: 489978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energy requirements of the binding and lytic steps of T lymphocyte-mediated cytolysis of leukemic cells in vitro.
    Berke G; Gabison D
    Eur J Immunol; 1975 Oct; 5(10):671-5. PubMed ID: 11993332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological studies of NK cell-deficient beige mice. II. Analysis of T-lymphocyte functions in beige mice.
    Baca ME; Mowat AM; Parrott DM
    Immunology; 1989 Jan; 66(1):131-7. PubMed ID: 15493275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesiveness and morphology of Lewis lung carcinoma variants influence their sensitivity to natural killer cytolysis and their metastatic capacity.
    Young MR; Duffie GP; Newby M
    Invasion Metastasis; 1987; 7(2):96-108. PubMed ID: 3583624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-C-reactive protein inhibits cytoskeletal rearrangement without altering calcium influx in natural killer cell activation.
    Khattri R; Hansen B; Nichols TC; Palmer KL; Gilman-Sachs A; Baum LL
    Cell Immunol; 1994 May; 155(2):457-75. PubMed ID: 8181076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrative approach to the proteolytic control of the cell-mediated cytotoxicity.
    Gabrielescu E
    Roum Arch Microbiol Immunol; 1992; 51(1-2):33-51. PubMed ID: 1333840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the mechanism of NK cell lysis.
    Quan PC; Ishizaka T; Bloom BR
    J Immunol; 1982 Apr; 128(4):1786-91. PubMed ID: 6895907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of inhibition of natural killing by a glycopeptide isolated from the K562 plasma membrane.
    Targan S; Decker JM; Ades EW
    Nat Immun Cell Growth Regul; 1983-1984; 3(3):113-23. PubMed ID: 6438498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.